EPISODE · Nov 14, 2017 · 28 MIN
Immuno Oncology 2017: Looking Back, Looking Forward with Rachel Laing and Olivier Lesueur
from Mendelspod Podcast · host Theral Timpson
Immuno oncology is now the dominant topic at Mendelspod. From shows with CEOs presenting new panels of predictive biomarker tests, to the firsts at the FDA with the CAR-T approvals as well as the first approval of a drug (Merck’s Keytruda) based on a common biomarker (MSI) rather than on a tumor type, to scientists discussing rare cells of the immune system, we had more podcasts on this topic than any other in 2017. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
NOW PLAYING
Immuno Oncology 2017: Looking Back, Looking Forward with Rachel Laing and Olivier Lesueur
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m